Ganciclovir implant in the treatment of cytomegalovirus retinitis

References

• de Jong MD, Galasso GJ, Gazzard B et al. Summary of the II International Symposium on Cytomegalovirus. Antiviral Res. 39(3), 141–162 (1998).
   PubMed Web of Science ®Google Scholar
• Gallant JE, Moore RD, Richman DD et al. Zidovudine Epidemiology Study Group. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J. Infect. Dis. 166(6), 1223–1227 (1992).
   PubMed Web of Science ®Google Scholar
• Pertel P, Hirschtick R, Phair J et al. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J. Acquir. Immune Defic. Syndr. 5(11), 1069–1074 (1992).
   PubMed Web of Science ®Google Scholar
• Hoover DR, Peng Y, Saah A et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch. Ophthalmol. 114(7), 821–827 (1996).
   PubMed Web of Science ®Google Scholar
• Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann. Intern. Med. 124(7), 633–642 (1996).
   PubMed Web of Science ®Google Scholar
• Holtzer CD, Jacobson MA, Hadley WK et al. Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994–1997. AIDS 12(14), 1931–1933 (1998).
   Google Scholar
• Palella FJ Jr, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338(13), 853–860 (1998).
   PubMed Web of Science ®Google Scholar
• Mahadevia PJ, Gebo KA, Pettit K, Dunn JP, Covington MT. The epidemiology, treatment patterns, and costs of cytomegalovirus retinitis in the post-HAART era among a national managed-care population. J. Acquir. Immune Defic. Syndr. 36(4), 972–977 (2004).
   PubMed Web of Science ®Google Scholar
• Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia JA. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch. Ophthalmol. 121(4), 466–476 (2003).
   PubMed Web of Science ®Google Scholar
• Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Foscarnet-ganciclovir cytomegalovirus retinitis trial 4: visual outcomes. Ophthalmology 101(7), 1250–1261 (1994).
   PubMed Web of Science ®Google Scholar
• Drew WL, Ives D, Lalezari JP et al. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N. Engl. J. Med. 333(10), 615–620 (1995).
   PubMed Web of Science ®Google Scholar
• Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. Ann. Intern. Med. 126(4), 264–274 (1997).
   PubMed Web of Science ®Google Scholar
• Smith CL. Local therapy for cytomegalovirus retinitis. Ann. Pharmacother. 32(2), 248–255 (1998).
   PubMed Web of Science ®Google Scholar
• Musch DC, Martin DF, Gordon JF et al. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant: the Ganciclovir Implant Study Group. N. Engl. J. Med. 337(2), 83–90 (1997).
   PubMed Web of Science ®Google Scholar
• Martin DF, Kuppermann BD, Wolitz RA, Palestine AG, Li H, Robinson CA. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant: Roche Ganciclovir Study Group. N. Engl. J. Med. 340(14), 1063–1070 (1999).
   PubMed Web of Science ®Google Scholar
• Smith TJ, Pearson PA, Blandford DL et al. Intravitreal sustained-release ganciclovir. Arch. Ophthalmol. 110(2), 255–258 (1992).
   PubMed Web of Science ®Google Scholar
• Martin DF, Parks DJ, Mellow SD et al. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant: A randomized controlled clinical trial. Arch. Ophthalmol. 112(12), 1531–1539 (1994).
   PubMed Web of Science ®Google Scholar
• Lim JI, Wolitz RA, Dowling AH, Bloom HR, Irvine AR, Schwartz DM. Visual and anatomic outcomes associated with posterior segment complications of ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis. Am. J. Ophthalmol. 127(3), 288–293 (1999).
   PubMed Web of Science ®Google Scholar
• Virata SR, Kylstra JA. Delayed vitreous hemorrhage after placement of a ganciclovir implant for cytomegalovirus retinitis. Am. J. Ophthalmol. 124(4), 557–558 (1997).
   PubMed Web of Science ®Google Scholar
• Guembel HO, Krieglsteiner S, Rosenkranz C, Hattenbach LO, Koch FH, Ohrloff C. Complications after implantation of intraocular devices in patients with cytomegalovirus retinitis. Graefes Arch. Clin. Exp. Ophthalmol. 237(10), 824–829 (1999).
   PubMed Web of Science ®Google Scholar
• Martin DF, Ferris FL, Parks DJ et al. Ganciclovir implant exchange: timing, surgical procedure, and complications. Arch. Ophthalmol. 115(11), 1389–1394 (1997).
   PubMed Web of Science ®Google Scholar
• Martin DF, Dunn JP, Davis JL et al. Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of the International AIDS Society-USA. Am. J. Ophthalmol. 127(3), 329–339 (1999).
   PubMed Web of Science ®Google Scholar
• Dunn JP, Van Natta M, Foster G et al. Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. Retina 24(2), 41–50 (2004).
   Google Scholar
• Shane TS, Martin DF, Endopthalmitis-Ganciclovir Implant Study Group. Endophthalmitis after ganciclovir implant in patients with AIDS and cytomegalovirus retinitis. Am. J. Ophthalmol. 136(4), 649–654 (2003).
   PubMed Web of Science ®Google Scholar
• Srivastava S, Taylor P, Wood LV, Lee SS, Robinson MR. Post-surgical scleritis associated with the ganciclovir implant. Ophthalmic Surg. Lasers Imaging 35(3), 254–255 (2004).
   PubMedGoogle Scholar
• Taguri AH, Dhillon B, Wharton SB, Kamal A. Foreign body reaction with delayed extrusion of ganciclovir implant in a patient with immune recovery vitritis syndrome. Am. J. Ophthalmol. 133(1), 147–149 (2002).
   PubMed Web of Science ®Google Scholar
• Charles NC, Freisberg L. Endophthalmitis associated with extrusion of a ganciclovir implant. Am. J. Ophthalmol. 133(2), 273–275 (2002).
   PubMed Web of Science ®Google Scholar
• Jaffe GJ, McCallum RM, Branchaud B, Skalak C, Butuner Z, Ashton P. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. Ophthalmology (2005) (In Press).
   Google Scholar
• Srivastava SK, Martin DF, Mellow SD et al. Pathological findings in eyes with the ganciclovir implant. Ophthalmology 112(5), 780–786 (2005).
   PubMed Web of Science ®Google Scholar
• Kuppermann BD, Quiceno JI, Flores-Aguilar M et al. Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy. J. Infect. Dis. 168(6), 1506–1509 (1993).
   PubMed Web of Science ®Google Scholar
• Arevalo JF, Gonzalez C, Capparelli EV et al. Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis. J. Infect. Dis. 172(4), 951–956 (1995).
   PubMed Web of Science ®Google Scholar
• Morlet N, Young S, Naidoo D, Graham G, Coroneo MT. High dose intravitreal ganciclovir injection provides a prolonged therapeutic intraocular concentration. Br. J. Ophthalmol. 80(3), 214–216 (1996).
   PubMed Web of Science ®Google Scholar
• Perkins SL, Yang CH, Ashton PA, Jaffe GJ. Pharmacokinetics of the ganciclovir implant in the silicone-filled eye. Retina 21(1), 10–14 (2001).
   PubMed Web of Science ®Google Scholar
• McGuire DE, McAulife P, Heinemann MH, Rahhal FM. Efficacy of the ganciclovir implant in the setting of silicone oil vitreous substitute. Retina 20(5), 20–23 (2000).
   Google Scholar
• Kuo IC, Imai Y, Shum C, Martin DF, Kuppermann BD, Margolis TP. Genotypic analysis of cytomegalovirus retinitis poorly responsive to intravenous ganciclovir but responsive to the ganciclovir implant. Am. J. Ophthalmol. 135(1), 20–25 (2003).
   PubMed Web of Science ®Google Scholar
• Jabs DA, Martin BK, Forman MS et al. Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis. Am. J. Ophthalmol. 135(1), 26–34 (2003).
   PubMed Web of Science ®Google Scholar
• Hu H, Jabs DA, Forman MS et al. Comparison of cytomegalovirus (CMV) UL97 gene sequences in the blood and vitreous of patients with acquired immunodeficiency syndrome and CMV retinitis. J. Infect. Dis. 185(7), 861–867 (2002).
   PubMed Web of Science ®Google Scholar
• Holbrook JT, Jabs DA, Weinberg DV et al. Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy. Arch. Ophthalmol. 121(1), 99–107 (2003).
   PubMed Web of Science ®Google Scholar
• Freeman WR, Friedberg DN, Berry C et al. Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am. J. Ophthalmol. 116(6), 713–720 (1993).
   PubMed Web of Science ®Google Scholar
• Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG). Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: Foscarnet-ganciclovir Cytomegalovirus Retinitis Trial. Am. J. Ophthalmol. 124(1), 61–70 (1997).
   PubMed Web of Science ®Google Scholar
• Kempen JH, Jabs DA, Dunn JP, West SK, Tonascia J. Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome. Arch. Ophthalmol. 119(1), 33–40 (2001).
   PubMed Web of Science ®Google Scholar
• Marx JL, Kapusta MA, Patel SS et al. Use of the ganciclovir implant in the treatment of recurrent cytomegalovirus retinitis. Arch. Ophthalmol. 114(7), 815–820 (1996).
   PubMedGoogle Scholar
• Anand R, Nightingale SD, Fish RH, Smith TJ, Ashton P. Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir. Arch. Ophthalmol. 111(2), 223–227 (1993).
   PubMed Web of Science ®Google Scholar
• Hatton MP, Duker JS, Reichel E, Morley MG, Puliafito CA. Treatment of relapsed cytomegalovirus retinitis with the sustained-release ganciclovir implant. Retina 18(1), 50–55 (1998).
   PubMed Web of Science ®Google Scholar
• Roth DB, Feuer WK, Blenke AJ, Davis JL. Treatment of recurrent cytomegalovirus retinitis with the ganciclovir implant. Am. J. Ophthalmol. 127(3), 276–282 (1999).
   PubMed Web of Science ®Google Scholar
• Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD+ T-cells in response to highly active antiretroviral therapy. J. Infect. Dis. 177(5), 1182–1187 (1998).
   PubMed Web of Science ®Google Scholar
• Jabs DA, Bolton SG, Dunn JP, Palestine AG. Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy. Am. J. Ophthalmol. 126(6), 817–822 (1998).
   PubMed Web of Science ®Google Scholar
• Whitcup SM, Fortin E, Lindblad AS et al. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis. J. Am. Med. Assoc. 282(17), 1633–1637 (1999).
   PubMed Web of Science ®Google Scholar
• Studies of Ocular Complications of AIDS Research Group. The AIDS Clinical Trials Group. The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. Am. J. Ophthalmol. 131(4), 457–467 (2001).
   PubMed Web of Science ®Google Scholar
• Nguyen QD, Kempen JH, Bolton SG, Dunn JP, Jabs DA. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am. J. Ophthalmol. 129(5), 634–639 (2000).
   PubMed Web of Science ®Google Scholar
• Jabs DA, Holbrook JT, Van Natta ML et al. Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology 112(5), 771–779 (2005).
   PubMed Web of Science ®Google Scholar
• Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia J. Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. Clin. Infect. Dis. 37(10), 1365–1373 (2003).
   PubMed Web of Science ®Google Scholar
• Imai Y, Shum C, Martin DF, Kuppermann BD, Drew WL, Margolis TP. Emergence of drug-resistant cytomegalovirus retinitis in the contralateral eyes of patients with AIDS treated with ganciclovir. J. Infect. Dis. 189(4), 611–615 (2004).
   PubMed Web of Science ®Google Scholar
• MacDonald JC, Karavellas MP, Torriani FJ et al. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis. Ophthalmology 107(5), 877–881 (2000).
   PubMed Web of Science ®Google Scholar
• Morley MG, Duker JS, Ashton P, Robinson MR. Replacing ganciclovir implants. Ophthalmology 102(3), 388–392 (1995).
   PubMed Web of Science ®Google Scholar
• Moore RD, Chaisson RE. Cost–utility analysis of prophylactic treatment with oral ganciclovir for cytomegalovirus retinitis. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 16(1), 15–21 (1997).
   Web of Science ®Google Scholar
• Yasukawa T, Kimura H, Tabata Y, Ogura Y. Biodegradable scleral plugs for vitreoretinal drug delivery. Adv. Drug Deliv. Rev. 52(1), 25–36 (2001).
   PubMed Web of Science ®Google Scholar
• Diaz-Llopis M, Espana E, Munoz G et al. High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS. Br. J. Ophthalmol. 78(2), 120–124 (1994).
   PubMed Web of Science ®Google Scholar
• Taskintuna I, Rahhal FM, Rao NA et al. Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrome (AIDS). Ophthalmology 104(11), 1827–1836 (1997).
   PubMed Web of Science ®Google Scholar
• Vitravene Study Group. Safety of intravitreous fomivirsen for treatment of cytomegalovirus retinitis in patients with AIDS. Am. J. Ophthalmol. 133(4), 484–498 (2002).
   PubMed Web of Science ®Google Scholar